SENDA BIOSCIENCES
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.
SENDA BIOSCIENCES
Industry:
Biotechnology Health Care Life Science
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sendabiosciences.com
Total Employee:
51+
Status:
Active
Contact:
617-430-4455
Email Addresses:
[email protected]
Total Funding:
309 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Nginx Euro Organization Schema CloudFront PostalAddress Schema LocalBusiness Schema
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-28 | Kintai Therapeutics | Kintai Therapeutics acquired by Senda Biosciences | N/A |
| 2020-08-01 | Omega Therapeutics | Omega Therapeutics acquired by Senda Biosciences | N/A |
Investors List
Ischyros New York
Ischyros New York investment in Series C - Senda Biosciences
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Senda Biosciences
Samsung Life Science Fund
Samsung Life Science Fund investment in Series C - Senda Biosciences
State of Michigan Retirement System
State of Michigan Retirement System investment in Series C - Senda Biosciences
Stage 1 Ventures
Stage 1 Ventures investment in Series C - Senda Biosciences
Mayo Clinic
Mayo Clinic investment in Series C - Senda Biosciences
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Senda Biosciences
Bluwave Capital
Bluwave Capital investment in Series C - Senda Biosciences
Longevity Vision Fund
Longevity Vision Fund investment in Series C - Senda Biosciences
Flagship Pioneering
Flagship Pioneering investment in Series C - Senda Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-26 | Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology |
Official Site Inspections
http://www.sendabiosciences.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.8 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
